Global Health Ltd

BSE
MEDANTA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Global Health Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
84.29% Gain from 52W Low
-12.8
TTM PE Ratio
High in industry
67.9
Price to Book Ratio
High in industry
11.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.5
RSI
RSI is mid-range
38.3
MFI
MFI is mid-range
41.9

Global Health Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Global Health Ltd shareholding Pattern

Promoter
33%
Foreign Institutions
12.1%
Mutual Funds
8.3%
Domestic Institutions
10.2%
Public
44.6%
Promoter
33%
Foreign Institutions
11.4%
Mutual Funds
8.6%
Domestic Institutions
11.2%
Public
44.4%
Promoter
33.1%
Foreign Institutions
10.7%
Mutual Funds
8.2%
Domestic Institutions
10.9%
Public
45.3%
Promoter
33.1%
Foreign Institutions
10.6%
Mutual Funds
8%
Domestic Institutions
10.8%
Public
45.6%
Promoter
33.1%
Foreign Institutions
9.9%
Mutual Funds
9.5%
Domestic Institutions
12.3%
Public
44.7%
Promoter
33.1%
Foreign Institutions
9.4%
Mutual Funds
9.8%
Domestic Institutions
12.6%
Public
45%

Global Health Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
1,223.90
10Day EMA
1,240.50
12Day EMA
1,245.00
20Day EMA
1,255.80
26Day EMA
1,261.30
50Day EMA
1,274.90
100Day EMA
1,253.20
200Day EMA
1,133.10
5Day SMA
1,226.20
10Day SMA
1,246.00
20Day SMA
1,274.30
30Day SMA
1,259.80
50Day SMA
1,279.20
100Day SMA
1,311.60
150Day SMA
1,234.00
200Day SMA
1,132.60
Delivery & Volume
Resistance & Support
1,210.55
Pivot
Resistance
First Resistance
1,219.90
Second Resistance
1,231.50
Third Resistance
1,240.85
Support
First Support
1,198.95
Second support
1,189.60
Third Support
1,178
Relative Strength Index
38.31
Money Flow Index
41.89
MACD
-16.28
MACD Signal
-8.30
Average True Range
40.97
Average Directional Index
25.08
Rate of Change (21)
-10.91
Rate of Change (125)
18.43
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Apollo Hospitals Enterprise Ltd.
92812.28
4727
6871.3
Fortis Healthcare Ltd.
36872.16
308.25
509.85
Narayana Hrudayalaya Ltd.
25410.22
972.05
1445.05
Aster DM Healthcare Ltd.
16763.66
293.85
558.3
Max Healthcare Institute Ltd.
89464.54
509.05
979.8
Krishna Institute of Medical Sciences Ltd.
17013.11
1625.05
2357

Global Health Ltd Company background

Founded in: 2004
Managing director: Naresh Kumar Trehan
Global Health Limited was incorporated as Global Health Private Limited on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited dated August 11, 2021 issued by the RoC. The Company was founded by Dr. Naresh Trehan, a worldrenowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multispeciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the Medanta brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients.In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on publicprivate partnership at Patna.In 2019, it commenced operations of new hospital at Lucknow.In 2020, Patna hospitals outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022. The Company has taken inhouse facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO)The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores.The Companys Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow hospital also added seven new OTs and have hired over 50 senior clinicians. Towards the end of FY23, Lucknow hospital commissioned the Siemens Varian EDGE Radiation Oncology machine the first in North India as well as set up a dedicated eICU Command Centre to assist in remote critical care management. The Companys Patna hospital added over 100 beds and 35+ doctors in FY23. In FY23, the Company also announced a new 300 bed hospital project in Indore under the assetlight OM model. It started Medanta Labs in January 2023. During the year 202223, GHL Pharma was incorporated as a whollyowned subsidiary on June 29, 2022.
Read More

Global Health Ltd FAQs

The past 1-year return of Global Health Ltd [MEDANTA] share was 72.3. The Global Health Ltd [MEDANTA] share hit a 1-year low of Rs. 615 and a 1-year high of Rs. 1513.75.

The Mutual Fund Shareholding was 8.27% at the end of .

You can easily buy Global Health Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -